Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
48.6M
-
Shares change
-
+14.1M
-
Total reported value, excl. options
-
$73M
-
Value change
-
+$20.3M
-
Put/Call ratio
-
2.94
-
Number of buys
-
55
-
Number of sells
-
-16
-
Price
-
$1.50
Significant Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q4 2016
92 filings reported holding IDRA - IDERA PHARMACEUTICALS INC - COM NEW as of Q4 2016.
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.6M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (10.3M shares), VANGUARD GROUP INC (4.85M shares), Broadfin Capital, LLC (4.43M shares), BlackRock Fund Advisors (3.29M shares), NATIXIS (3.15M shares), JPMORGAN CHASE & CO (2.97M shares), BlackRock Institutional Trust Company, N.A. (2.56M shares), FMR LLC (2.51M shares), RA CAPITAL MANAGEMENT, LLC (2.25M shares), and STATE STREET CORP (1.55M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.